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LFCA was anastomosed on the right coronary artery in 10 
cases, the first marginal branch of the circumflex artery in 5, 
the first diagonal branch in 5, the LAD in 3, the intermediary 
artery in 1, and the posterior descending artery in another 
case. In 21 cases, proximal anastomoses of the descending 
branch of the LFCA were carried out on the ascending aorta, 
and in 4 cases they were carried out either on the pedunculat-
ed right ITA or left ITA, forming a Y-shaped graft. The aver-
age length of the descending branch of the LFCA was 16 cm 
(range 14-20 cm). Clinical follow-up was complete for all 
patients with a mean follow-up of 8 months (range 2-26 
months). One patient who was operated on on an urgent basis 
with an ejection fraction of 20% died of irreversible left ven-
tricular failure on the fifth postoperative day. A postoperative 
coronary angiogram was repeated in 4 patients, and in only 1 
of them was the descending branch of the LFCA found to be 
occluded. The other patients continue to be followed-up by 
periodic treadmill tests and remain clinically free of symp-
toms. During the beginning of our experience with the 
descending branch of the LFCA, we observed that this artery 
was unsuitable for use in some cases. The presence of a poor-
ly developed artery (Fig 2A) and of macroscopic atheroma-
tous lesions in the artery itself preclude its harvesting. For 
these reasons, we considered it necessary to perform bilateral 
femoral arteriography before surgery, during coronary 
angiography, for patients in whom the 'use of the descending 
branch of the LFCA might be justified. Arteriographic evalu-
ation provided further information on the anatomic variations 
of this artery such as the LFCA arising from the common 
femoral artery or a hypoplastic LFCA being sometimes 
replaced by small branches taking their origin from the deep 
or superficial femoral arteries. The anatomy of the LFCA can 
be different between the right and left sides in the same per-
son. Moreover, radiologic evaluation allows the detection of 
some occlusive or stenotic lesions of the superficial femoral 
arteries . for which the descending branch of the LFCA con-
tributes to the collateral circulation of the limb (Fig 2B). 
Histopathologic examination of the harvested descending 
branches of the LFCA revealed that this artery can contain 
macroscopically occult atheromatous lesions, sometimes even 
with microscopic calcified deposits, which could result in ear-
lier occlusion of the graft after the operation. 
In conclusion, although we totally agree with the conclu-
sions reported by the authors regarding this new arterial con-
duit, we would like to emphasize the importance of a preoper-
ative bil;1teral arteriographic evaluation of the femoral arteries 
and thatiof LFCAs, as we systematically do for thoracic arter-
ies. We believe that this evaluation can avoid useless attempts 
at harvesting. Attractiveness of the descending branch of the 
LFCA as an arterial conduit will depend on its patency rate in 
the lon$ term and the enthusiasm of surgeons to use it. 
Bernard Faidutti, MD 
Afksendiyos Kalangos, MD, PhD 
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A successful treatment of serous leakage from a 
polytetrafluoroethylene Blalock-Taussig shunt with 
intravenous fibrinogen administration 
To the Editor: 
Occasionally, excessive serous fluid leakage occurs as a 
complication after the modified polytetrafluoroethylene 
(PTFE) Blalock-Taussig (B-T) shunt. The estimated frequen-
cy of this complication is reported as approximately 20%,1,2 
but the mechanism is not clearly defined. We present a case of 
serous leakage through a modified B-T shunt treated with 
intravenous fibrinogen administration and describe our 
hypothesis about the role of fibrinolysis in this problem. 
A 3-year-old boy (11.5 kg) with single right ventricle and 
pulmonary stenosis was admitted for the treatment of cyanosis 
and exercise intolerance. A blood test revealed polycythemia 
with a hemoglobin level of 20.8 g/dL. We decided not to pro-
ceed directly to a Fontan procedure because of the lack of 
direct measurement of pulmonary arterial pressure and pul-
monary vascular resistance (the catheter did not go through 
the narrow ventricular outflow tract). As a preparation for a 
Fontan-type procedure, the boy underwent a left modified B-
T shunt with a 5-mm PTFE shunt. Anticoagulation was initi-
ated on the first postoperative day with a continuous heparin 
infusion (200 unitsfkg per day; Novo Heparin, Hoechst 
Marion Roussel, AG, Frankfurt, Germany) and an oral admin-
istration of ticlopidine hydrochloride (5 mgfkg per day; 
Panaldine, Dai-Ichi, Inc, Tokyo, Japan). On the third postop-
erative day, the chest tube drainage increased appreciably and 
the anticoagulation therapy was discontinued. The drainage 
continued for more than a week, with excessive serous fluid 
losses averaging 700 mL daily. The blood test revealed a 
marked decrease in total plasma protein (4.2 g/dL) and plas-
ma fibrinogen (93.6 mg/dL) levels. The massive leakage con-
tinued and plasma protein and fibrinogen did not increase 
despite the infusion of packs of frozen plasma. We adminis-
tered fibrinogen (heated and freeze-dried human fibrinogen; 
Fibrinogen HT, Yoshitomi, Inc, Osaka, Japan) intravenously, 
200 mgfkg per day, for 2 days. The leakage stopped instantly 
and the fibrinogen level increased to more than 300 mg/dL. 
The chest tube was removed and the patient was discharged 
after a catheterization. Anticoagulation therapy was never 
resumed. 
Three weeks later, the boy was readmitted with dyspnea, 
chest pain, and increasing cyanosis. A chest x-ray film 
revealed a massive pleural effusion on the left side, and a 
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chest tube was inserted. Chest drainage continued for several 
days, with excessive serous fluid losses and decreased plasma 
protein (4.4 g/dL) and fibrinogen (71.3 mg/dL) levels. 
Fibrinogen (200 mglkg per day for 2 days) was administered 
again, and the fluid leakage stopped completely within 2 days. 
On the basis of a high D-dimer level (736 ng/mL) detected 
after the second fibrinogen administration, we speculated that 
the fibrinolytic system had been greatly amplified in this 
cyanotic patient. Therefore, we started an oral medication of 
tranexamic acid (Transamin-G; Dai-Ichi, Inc, Tokyo, Japan) 
30 mglkg daily as an antifibrinolytic therapy. Additional pro-
phylactic fibrinogen infusion was achieved twice at 2-week 
intervals. Since then, the plasma fibrinogen level has been 
within normal range (no less than 170 mgldL), and the plas-
ma D-dimer level has been maintained at a relatively lower 
level (200 to 600 ng/mL), leaving the patient in stable condi-
tion without any fluid leakage. Neither thrombocytopenia nor 
bleeding tendency was observed. No thrombotic events 
occurred. A bidirectional Glenn shunt was successfully done 
6 months after the B-T shunt. 
LeBlanc and associates2 first described excessive fluid leak-
age after a modified B-T shunt. Bolton and Cannon3 suggest-
ed that rapid wetting of the graft with organic solvents or a 
high blood flow with faulty formation of fibrin may be 
responsible for the leakage. However, the mechanism still 
remains unclear. In most of the cases' previously described, 
conservative management failed and surgical interventions 
were required. Maitland and coworkers4 reported 2 cases in 
which leakage was controlled with intraluminal fibrin glue. 
Noyez and Daenen1 reported the case of a patient treated with 
fibrin glue and collagen fleece wrapping. Intravenous fibrino-
gen administration was first described by Suzuki and associ-
ates5 as an effective conservative management of the leakage. 
Human fibrinogen products were originally developed for 
congenital fibrinogenopenia and are commercially available 
in Germany and Japan. According to their report, 7 patients 
were successfully treated with fibrinogen administration 
(150-200 mglkg per day for 3 or 4 days), and in 2 of those 
cases the plasma fibrinogen level was much lower than the 
normal range at the beginning of the leakage. As we 
described, the fact that plasma fibrinogen level decreased and 
plasma D-dimer level increased at the beginning of the fluid 
losses may be an important clue to the mechanism of leakage. 
We speculate that the fibrinolytic system could be greatly 
amplified in some cyanotic patients with polycythemia 
against great thrombotic tendency owing to high blood vis-
cosity. A probable explanation is that the fibrin cross-linking 
step and newly formed fibrin clots in a PTFE graft wall could 
be easily impaired and degraded when this overwhelming fib-
rinolytic regulation occurs. Once the strong fibrinolysis 
begins; a large amount of fibrinogen may need to be supplied 
until newly formed cross-linked fibrin is tightened and subse-
quent clot formation is completed. Platelet function of 
patients with polycythemia may play another important role 
in this problem. In our preliminary data of the patients, very 
weak aggregation and poor a-granule release response have 
Letters to the Editor 1231 
been observed. We hypothesize that both strong fibrinolytic 
response and weakened platelet function could be the physio-
logic adaptation phenomenon against the great thrombotic 
risk. Intravenous fibrinogen administration is effective and the 
combination of fibrinogen and antifibrinolytic therapy may be 
the best conservative management available for serous leak-
age through PTFE so far. Further investigations are needed to 
prove our hypothesis. 
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Aortic function in patients during intra-aortic balloon 
pumping determined by the pressure-diameter 
relation 
To the Editor: 
Stefanadis and associates 1 provide an important analysis of 
aortic function in patients during intra-aortic balloon pump-
ing, which aids in the understanding of the improved circula-
tory function that results from its use. However, two points 
need further clarification. 
First, in Fig 4 they state that the fourth derivative of the aor-
tic pressure and diameter was used to estimate (1) minimum 
aortic pressure and diameter and (2) the point of inflection of 
the aortic pressure and diameter, thus allowing calculation of 
the pressure augmentation index. The fourth derivative has 
been previously described as the optimum way of deriving 
these points.2 
The use of the fourth derivative is against the basic princi-
ples of calculus, in which the first derivative is used to eval-
uate minima and maxima, with the second derivative used to 
distinguish between these and points of inflexion, negative at 
